What is the role of neoadjuvant breast radiation in patients with triple negative breast cancer progressing on AC-T?

There is no standard treatment in this setting. If a patient is not a candidate for clinical trial, we have been doing RT with concurrent carboplatinum or xeloda with the hope of making the disease operable. In our experience, response is mixed with a set of patient making it to operable stage.